To determine if the expression of MHC class I heavy chain proteins in pancreatic cancer cells is increased by M344 treatment, we performed immunoblot analysis on lysates of M344-treated S2-013 pancreatic cancer cells with an antibody recognizing the human MHC class I heavy chains HLA-B and HLA-C. Here, HLA-B is linked to familial pancreatic carcinoma.